4//SEC Filing
High Katherine A 4
Accession 0001209191-21-040296
CIK 0001674416other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 5:39 PM ET
Size
5.5 KB
Accession
0001209191-21-040296
Insider Transaction Report
Form 4
High Katherine A
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-10+10,000→ 10,000 totalExercise: $123.71Exp: 2031-06-10→ Common Shares (10,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 10, 2021 with respect to 10,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2021; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2022 Annual General Meeting of Shareholders.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001631248
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 5:39 PM ET
- Size
- 5.5 KB